← Leaderboards
Robert L Moritz
Institute For Systems Biology
$12,597,169
Attributed
$20,599,132
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,599,132 · 9
By mechanism
R01$11,427,280 · 2
RC2$4,576,646 · 1
P50$2,202,887 · 1
S10$1,176,434 · 2
R21$1,044,085 · 2
R03$171,800 · 1
Top collaborators
- Eric Deutsch9 shared
- Edwin K Silverman8 shared
- Leroy E Hood2 shared
Others in their field
Top investigators on “Proteomics”
- David Heimbrook · Leidos Biomedical Research, Inc.$318,825,229
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,612,005
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$70,176,616
- Rolf Apweiler · European Molecular Biology Laboratory$67,677,991
- Daniel Ernest Ford · Johns Hopkins University$67,257,868
Research focus
ProteomicsProteinsProteomeMass Spectrum AnalysisTechnologySamplingBasePost-Translational Protein ProcessingCellsBiologicalValidationDetectionEvaluationOpen SourcePeptidesAlgorithmsCommunitiesComputer SoftwareInstrumentationBiological MarkersClinically RelevantDatabasesGenesData Set
Grant awards (32)
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$863,197
R01 · FY2025 · HL
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$854,782
R01 · FY2024 · HL
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$897,506
R01 · FY2023 · HL
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$937,171
R01 · FY2022 · HL
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$524,789
R01 · FY2021 · GM
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computing$100,000
R01 · FY2021 · GM
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$898,437
R01 · FY2020 · HL
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$524,789
R01 · FY2020 · GM
Proteogenomic resource for the development of novel markers for Lyme disease$228,522
R21 · FY2020 · AI · contact PI
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$898,561
R01 · FY2019 · HL
Acquisition of Fusion Lumos Orbitrap mass spectrometer$600,000
S10 · FY2019 · OD · contact PI
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$524,789
R01 · FY2019 · GM
Proteogenomic resource for the development of novel markers for Lyme disease$293,522
R21 · FY2019 · AI · contact PI
Novel peptide based biomarkers for Lyme disease diagnostics$228,520
R21 · FY2019 · AI · contact PI
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$905,200
R01 · FY2018 · HL
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$524,789
R01 · FY2018 · GM
Novel peptide based biomarkers for Lyme disease diagnostics$293,521
R21 · FY2018 · AI · contact PI
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics$923,458
R01 · FY2017 · HL
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$509,505
R01 · FY2017 · GM
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$509,505
R01 · FY2016 · GM
Proteomic Core$424,092
P50 · FY2016 · GM · contact PI
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$509,505
R01 · FY2015 · GM
Proteomic Core$413,521
P50 · FY2015 · GM · contact PI
Development of Trans Proteomic Pipeline, an Analysis Suite for Mass Spectrometry$521,297
R01 · FY2014 · GM
Proteomic Core$425,478
P50 · FY2014 · GM · contact PI
Proteomic Core$443,387
P50 · FY2013 · GM · contact PI
Proteomic Core$496,409
P50 · FY2012 · GM · contact PI
Proteomic and lipidomic profiling of tumor-derived exosomes for cancer prevention$85,900
R03 · FY2012 · CA · contact PI
FAIMS-Selected Reaction Monitoring to Quantitative Protein Networks in Disease$576,434
S10 · FY2011 · RR · contact PI
Proteomic and lipidomic profiling of tumor-derived exosomes for cancer prevention$85,900
R03 · FY2011 · CA · contact PI
Complete Human Peptide- and MRM-Atlas$2,301,879
RC2 · FY2010 · HG · contact PI
Complete Human Peptide- and MRM-Atlas$2,274,767
RC2 · FY2009 · HG · contact PI